1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Non-small Cell Lung Cancer Therapeutics Industry 2015 Market Research Report

Summary


The Global Non-small Cell Lung Cancer Therapeutics Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Non-small Cell Lung Cancer Therapeutics industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Non-small Cell Lung Cancer Therapeutics market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.The Non-small Cell Lung Cancer Therapeutics industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 230 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

Global Non-small Cell Lung Cancer Therapeutics Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Non-small Cell Lung Cancer Therapeutics
1.2 Classification of Non-small Cell Lung Cancer Therapeutics
1.3 Applications of Non-small Cell Lung Cancer Therapeutics
1.4 Industry Chain Structure of Non-small Cell Lung Cancer Therapeutics
1.5 Industry Regional Overview of Non-small Cell Lung Cancer Therapeutics
1.6 Industry Policy Analysis of Non-small Cell Lung Cancer Therapeutics
1.7 Industry News Analysis of Non-small Cell Lung Cancer Therapeutics

2 Manufacturing Cost Structure Analysis of Non-small Cell Lung Cancer Therapeutics
2.1 Raw Material Suppliers and Price Analysis of Non-small Cell Lung Cancer Therapeutics
2.2 Equipment Suppliers and Price Analysis of Non-small Cell Lung Cancer Therapeutics
2.3 Labor Cost Analysis of Non-small Cell Lung Cancer Therapeutics
2.4 Other Costs Analysis of Non-small Cell Lung Cancer Therapeutics
2.5 Manufacturing Cost Structure Analysis of Non-small Cell Lung Cancer Therapeutics
2.6 Manufacturing Process Analysis of Non-small Cell Lung Cancer Therapeutics

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of Global Key Non-small Cell Lung Cancer Therapeutics Manufacturers in 2014
3.3 RandD Status and Technology Source of Global Non-small Cell Lung Cancer Therapeutics Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of Global Non-small Cell Lung Cancer Therapeutics Key Manufacturers in 2014

4 Production Analysis of Non-small Cell Lung Cancer Therapeutics by Regions, Technology, and Applications
4.1 Global Production of Non-small Cell Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) 2010-2015
4.2 Global Production of Non-small Cell Lung Cancer Therapeutics by Technology 2010-2015
4.3 Global Production of Non-small Cell Lung Cancer Therapeutics by Applications 2010-2015
4.4 Price Analysis of Global Non-small Cell Lung Cancer Therapeutics Key Manufacturers in 2015
4.5 US Capacity, Production, Price, Cost and Revenue of Non-small Cell Lung Cancer Therapeutics 2010-2015
4.6 EU Capacity, Production, Price, Cost and Revenue of Non-small Cell Lung Cancer Therapeutics 2010-2015
4.7 Japan Capacity, Production, Price, Cost and Revenue of Non-small Cell Lung Cancer Therapeutics 2010-2015
4.8 China Capacity, Production, Price, Cost and Revenue of Non-small Cell Lung Cancer Therapeutics 2010-2015
4.9 US Supply, Import, Export and Consumption of Non-small Cell Lung Cancer Therapeutics 2010-2015
4.10 EU Supply, Import, Export and Consumption of Non-small Cell Lung Cancer Therapeutics 2010-2015
4.11 Japan Supply, Import, Export and Consumption of Non-small Cell Lung Cancer Therapeutics 2010-2015
4.12 China Supply, Import, Export and Consumption of Non-small Cell Lung Cancer Therapeutics 2010-2015

5 Sales and Revenue Analysis of Non-small Cell Lung Cancer Therapeutics by Regions
5.1 Global Sales of Non-small Cell Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) 2010-2015
5.2 Global Revenue of Non-small Cell Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) 2010-2015
5.3 Global Price Analysis of Non-small Cell Lung Cancer Therapeutics Sales by Regions (US, EU, China, Japan, etc.) 2010-2015
5.4 Global Price, Cost and Gross of Non-small Cell Lung Cancer Therapeutics 2010-2015

6 Analysis of Non-small Cell Lung Cancer Therapeutics Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity and Production of Non-small Cell Lung Cancer Therapeutics 2010-2015
6.2 Production Market Share Analysis of Non-small Cell Lung Cancer Therapeutics 2010-2015
6.3 Sales Overview of Non-small Cell Lung Cancer Therapeutics 2010-2015
6.4 Supply, Sales and Shortage of Non-small Cell Lung Cancer Therapeutics 2010-2015
6.5 Import, Export and Consumption of Non-small Cell Lung Cancer Therapeutics 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Non-small Cell Lung Cancer Therapeutics 2010-2015

7 Analysis of Non-small Cell Lung Cancer Therapeutics Industry Key Manufacturers
7.1 AstraZeneca
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity Production Price Cost Production Value
7.1.4 Contact Information

7.2 Celgene
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity Production Price Cost Production Value
7.2.4 Contact Information

7.3 Eli Lilly
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity Production Price Cost Production Value
7.3.4 Contact Information

7.4 F. Hoffmann-La Roche
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity Production Price Cost Production Value
7.4.4 Contact Information

7.5 Pfizer
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity Production Price Cost Production Value
7.5.4 Contact Information

7.6 Aetna
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity Production Price Cost Production Value
7.6.4 Contact Information

7.7 Boehringer Ingelheim
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity Production Price Cost Production Value
7.7.4 Contact Information

7.8 Celldex
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity Production Price Cost Production Value
7.8.4 Contact Information

7.9 Eisai
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity Production Price Cost Production Value
7.9.4 Contact Information

7.10 GlaxoSmithKline
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity Production Price Cost Production Value
7.10.4 Contact Information

7.11 IMClone
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity Production Price Cost Production Value
7.11.4 Contact Information

7.12 Merck Serono
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity Production Price Cost Production Value
7.12.4 Contact Information

7.13 Novartis
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity Production Price Cost Production Value
7.13.4 Contact Information

7.14 Qiagen
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity Production Price Cost Production Value
7.14.4 Contact Information

7.15 OncoGenex
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity Production Price Cost Production Value
7.15.4 Contact Information

7.16 OSI Pharmaceuticals
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity Production Price Cost Production Value
7.16.4 Contact Information

7.17 Pierre Fabre
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity Production Price Cost Production Value
7.17.4 Contact Information

7.18 Sanofi
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity Production Price Cost Production Value
7.18.4 Contact Information

7.19 Synta
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity Production Price Cost Production Value
7.19.4 Contact Information

8 Price and Gross Margin Analysis
8.1 Analysis of Price, Supply and Consumption
8.1.1 Price Analysis
8.1.2 Supply Analysis
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Non-small Cell Lung Cancer Therapeutics Product Types
8.5 Market Share Analysis of Different Non-small Cell Lung Cancer Therapeutics Price Levels
8.6 Gross Margin Analysis of Different Non-small Cell Lung Cancer Therapeutics Applications

9 Marketing Trader or Distributor Analysis of Non-small Cell Lung Cancer Therapeutics
9.1 Marketing Channels Status of Non-small Cell Lung Cancer Therapeutics
9.2 Traders or Distributors of Non-small Cell Lung Cancer Therapeutics with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Non-small Cell Lung Cancer Therapeutics
9.4 Regional Import, Export and Trade Analysis of Non-small Cell Lung Cancer Therapeutics

10 Development Trend of Non-small Cell Lung Cancer Therapeutics Industry 2015-2020
10.1 Capacity and Production Overview of Non-small Cell Lung Cancer Therapeutics 2015-2020
10.2 Production Market Share Analysis of Non-small Cell Lung Cancer Therapeutics 2015-2020
10.3 Sales Overview of Non-small Cell Lung Cancer Therapeutics 2015-2020
10.4 Supply, Sales, and Shortage of Non-small Cell Lung Cancer Therapeutics 2015-2020
10.5 Import, Export and Consumption of Non-small Cell Lung Cancer Therapeutics 2015-2020
10.6 Cost, Price, Revenue and Gross Margin of Non-small Cell Lung Cancer Therapeutics 2015-2020

11 Industry Chain Suppliers of Non-small Cell Lung Cancer Therapeutics with Contact Information
11.1 Major Raw Materials Suppliers of Non-small Cell Lung Cancer Therapeutics with Contact Information
11.2 Manufacturing Equipment Suppliers of Non-small Cell Lung Cancer Therapeutics with Contact Information
11.3 Major Suppliers of Non-small Cell Lung Cancer Therapeutics with Contact Information
11.4 Key Consumers of Non-small Cell Lung Cancer Therapeutics with Contact Information
11.5 Supply Chain Relationship Analysis of Non-small Cell Lung Cancer Therapeutics

12 New Project Investment Feasibility Analysis of Non-small Cell Lung Cancer Therapeutics
12.1 New Project SWOT Analysis of Non-small Cell Lung Cancer Therapeutics
12.2 New Project Investment Feasibility Analysis of Non-small Cell Lung Cancer Therapeutics

13 Conclusion of the Global Non-small Cell Lung Cancer Therapeutics Industry 2015 Market Research Report




List of Tables and Figures
Figure Picture of Non-small Cell Lung Cancer Therapeutics
Table Product Specifications of Non-small Cell Lung Cancer Therapeutics
Figure Global Sales Market Share of Non-small Cell Lung Cancer Therapeutics by Product Types in 2014
Figure Global Sales Market Share of Non-small Cell Lung Cancer Therapeutics by Applications in 2014
Figure Industry Chain Structure of Non-small Cell Lung Cancer Therapeutics
Table Global Major Non-small Cell Lung Cancer Therapeutics Manufacturers
Table Industry Policy of Non-small Cell Lung Cancer Therapeutics
Table Industry News List of Non-small Cell Lung Cancer Therapeutics
Table Manufacturing Cost Structure Analysis of Non-small Cell Lung Cancer Therapeutics in 2014
Figure Manufacturing Process Analysis of Non-small Cell Lung Cancer Therapeutics
Table Capacity (K Person-portion) and Commercial Production Date of Global Non-small Cell Lung Cancer Therapeutics Key Manufacturers in 2014
Table Manufacturing Plants Distribution of Global Key Non-small Cell Lung Cancer Therapeutics Manufacturers in 2014
Table RandD Status and Technology Source of Global Non-small Cell Lung Cancer Therapeutics Key Manufacturers in 2014
Table Raw Materials Sources Analysis of Global and China Non-small Cell Lung Cancer Therapeutics Key Manufacturers in 2014
Table Global Production of Non-small Cell Lung Cancer Therapeutics by Regions 2010-2015 (K Person-portion)
Figure Global Production Market Share of Non-small Cell Lung Cancer Therapeutics by Regions in 2010
Figure Global Production Market Share of Non-small Cell Lung Cancer Therapeutics by Regions in 2011
Figure Global Production Market Share of Non-small Cell Lung Cancer Therapeutics by Regions in 2012
Figure Global Production Market Share of Non-small Cell Lung Cancer Therapeutics by Regions in 2013
Figure Global Production Market Share of Non-small Cell Lung Cancer Therapeutics by Regions in 2014
Figure Global Production Market Share of Non-small Cell Lung Cancer Therapeutics by Regions in 2015
Figure Global Production Market Share of Non-small Cell Lung Cancer Therapeutics by Technology in 2010
Figure Global Production Market Share of Non-small Cell Lung Cancer Therapeutics by Technology in 2011
Figure Global Production Market Share of Non-small Cell Lung Cancer Therapeutics by Technology in 2012
Figure Global Production Market Share of Non-small Cell Lung Cancer Therapeutics by Technology in 2013
Figure Global Production Market Share of Non-small Cell Lung Cancer Therapeutics by Technology in 2014
Figure Global Production Market Share of Non-small Cell Lung Cancer Therapeutics by Technology in 2015
Figure Global Production Market Share of Non-small Cell Lung Cancer Therapeutics by Applications in 2010
Figure Global Production Market Share of Non-small Cell Lung Cancer Therapeutics by Applications in 2011
Figure Global Production Market Share of Non-small Cell Lung Cancer Therapeutics by Applications in 2012
Figure Global Production Market Share of Non-small Cell Lung Cancer Therapeutics by Applications in 2013
Figure Global Production Market Share of Non-small Cell Lung Cancer Therapeutics by Applications in 2014
Figure Global Production Market Share of Non-small Cell Lung Cancer Therapeutics by Applications in 2015
Figure Price Comparison of Global Non-small Cell Lung Cancer Therapeutics Key Manufacturers in 2015 (USD/Person-portion)
Table US Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Non-small Cell Lung Cancer Therapeutics 2010-2015
Table EU Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Non-small Cell Lung Cancer Therapeutics 2010-2015
Table Japan Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Non-small Cell Lung Cancer Therapeutics 2010-2015
Table China Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Non-small Cell Lung Cancer Therapeutics 2010-2015
Table US Supply, Import, Export and Consumption of Non-small Cell Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table EU Supply, Import, Export and Consumption of Non-small Cell Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table Japan Supply, Import, Export and Consumption of Non-small Cell Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table China Supply, Import, Export and Consumption of Non-small Cell Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table Global Sales of Non-small Cell Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) 2010-2015 (K Person-portion)
Figure Global Sales of Non-small Cell Lung Cancer Therapeutics by Regions (EU, China, Japan, etc.) in 2010 (K Person-portion)
Figure Global Sales of Non-small Cell Lung Cancer Therapeutics by Regions (EU, China, Japan, etc.) in 2011 (K Person-portion)
Figure Global Sales of Non-small Cell Lung Cancer Therapeutics by Regions (EU, China, Japan, etc.) in 2012 (K Person-portion)
Figure Global Sales of Non-small Cell Lung Cancer Therapeutics by Regions (EU, China, Japan, etc.) in 2013 (K Person-portion)
Figure Global Sales of Non-small Cell Lung Cancer Therapeutics by Regions (EU, China, Japan, etc.) in 2014 (K Person-portion)
Figure Global Sales of Non-small Cell Lung Cancer Therapeutics by Regions (EU, China, Japan, etc.) in 2015 (K Person-portion)
Table Global Revenue of Non-small Cell Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) 2010-2015 (M USD)
Figure Global Revenue of Non-small Cell Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) in 2010 (M USD)
Figure Global Revenue of Non-small Cell Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) in 2011 (M USD)
Figure Global Revenue of Non-small Cell Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) in 2012 (M USD)
Figure Global Revenue of Non-small Cell Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) in 2013 (M USD)
Figure Global Revenue of Non-small Cell Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) in 2014 (M USD)
Figure Global Revenue of Non-small Cell Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) in 2015 (M USD)
Table Sale Price of Non-small Cell Lung Cancer Therapeutics by Regions (US, EU, China, Japan, etc.) 2010-2015 (USD/Person-portion)
Figure Global Price Analysis of Non-small Cell Lung Cancer Therapeutics 2010-2015 (USD/Person-portion)
Figure Global Cost Analysis of Non-small Cell Lung Cancer Therapeutics 2010-2015 (USD/Person-portion)
Figure Global Gross Analysis of Non-small Cell Lung Cancer Therapeutics 2010-2015
Table Global and Major Manufacturers Capacity of Non-small Cell Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table Global Capacity Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers 2010-2015
Table Global and Major Manufacturers Production of Non-small Cell Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table Global Production Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers 2010-2015
Figure Global Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Non-small Cell Lung Cancer Therapeutics 2010-2015
Figure Global Capacity Utilization Rate of Non-small Cell Lung Cancer Therapeutics 2010-2015
Table Global and Major Manufacturers Revenue of Non-small Cell Lung Cancer Therapeutics 2010-2015 (M USD)
Table Global Revenue Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers 2010-2015
Figure Global Revenue (M USD) and Growth Rate of Non-small Cell Lung Cancer Therapeutics 2010-2015
Table China and Major Manufacturers Capacity of Non-small Cell Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table Capacity Market Share of China Major Non-small Cell Lung Cancer Therapeutics Manufacturers 2010-2015
Table China and Major Manufacturers Production 2010-2015 (K Person-portion)
Table Production Market Share of China Major Manufacturers 2010-2015
Figure China Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Non-small Cell Lung Cancer Therapeutics 2010-2015
Figure China Capacity Utilization Rate of Non-small Cell Lung Cancer Therapeutics 2010-2015
Table China and Major Manufacturers Revenue of Non-small Cell Lung Cancer Therapeutics 2010-2015 (M USD)
Table Revenue Market Share of China Major Manufacturers 2010-2015
Figure China Revenue (M USD) and Growth Rate of Non-small Cell Lung Cancer Therapeutics 2010-2015
Figure Global Production Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers in 2010
Figure Global Production Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers in 2011
Figure Global Production Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers in 2012
Figure Global Production Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers in 2013
Figure Global Production Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers in 2014
Figure Global Production Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers in 2015
Figure China Production Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers in 2010
Figure China Production Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers in 2011
Figure China Production Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers in 2012
Figure China Production Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers in 2013
Figure China Production Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers in 2014
Figure China Production Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers in 2015
Figure Global Sales (K Person-portion) and Growth Rate of Non-small Cell Lung Cancer Therapeutics 2010-2015
Figure China Sales (K Person-portion) and Growth Rate of Non-small Cell Lung Cancer Therapeutics 2010-2015
Table Global Supply, Sales and Shortage of Non-small Cell Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table China Supply, Sales and Shortage of Non-small Cell Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table China Import, Export and Consumption of Non-small Cell Lung Cancer Therapeutics 2010-2015 (K Person-portion)
Table Price of Global Non-small Cell Lung Cancer Therapeutics Major Manufacturers 2010-2015 (USD/Person-portion)
Figure Price Comparison by Global Major Non-small Cell Lung Cancer Therapeutics Manufacturers in 2014 (USD/Person-portion)
Table Gross Margin of Global Non-small Cell Lung Cancer Therapeutics Major Manufacturers 2010-2015
Figure Gross Margin of Global Non-small Cell Lung Cancer Therapeutics Major Manufacturers in 2014
Table Global and Major Manufacturers Revenue of Non-small Cell Lung Cancer Therapeutics 2010-2015 (M USD)
Table Global Revenue Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers 2010-2015
Figure Global Revenue Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers in 2011
Figure Global Revenue Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers in 2012
Figure Global Revenue Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers in 2013
Figure Global Revenue Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers in 2014
Figure Global Revenue Market Share of Major Non-small Cell Lung Cancer Therapeutics Manufacturers in 2015
Table China and Major Manufacturers of Non-small Cell Lung Cancer Therapeutics 2010-2015 (M USD)
Table Revenue Market Share of China Non-small Cell Lung Cancer Therapeutics Major Manufacturers 2010-2015
Table Global Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Non-small Cell Lung Cancer Therapeutics 2010-2015
Table China Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Non-small Cell Lung Cancer Therapeutics 2010-2015
Figure AstraZeneca Non-small Cell Lung Cancer Therapeutics Product Picture
Table AstraZeneca Non-small Cell Lung Cancer Therapeutics Product Specification
Table 2010-2015 AstraZeneca Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 AstraZeneca Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 AstraZeneca Non-small Cell Lung Cancer Therapeutics Product Production Global Market Share
Figure Celgene Non-small Cell Lung Cancer Therapeutics Product Picture
Table Celgene Non-small Cell Lung Cancer Therapeutics Product Specification
Table 2010-2015 Celgene Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Celgene Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Celgene Non-small Cell Lung Cancer Therapeutics Product Production Global Market Share
Figure Eli Lilly Non-small Cell Lung Cancer Therapeutics Product Picture
Table Eli Lilly Non-small Cell Lung Cancer Therapeutics Product Specification
Table 2010-2015 Eli Lilly Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Eli Lilly Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Eli Lilly Non-small Cell Lung Cancer Therapeutics Product Production Global Market Share
Figure F. Hoffmann-La Roche Non-small Cell Lung Cancer Therapeutics Product Picture
Table F. Hoffmann-La Roche Non-small Cell Lung Cancer Therapeutics Product Specification
Table 2010-2015 F. Hoffmann-La Roche Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 F. Hoffmann-La Roche Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 F. Hoffmann-La Roche Non-small Cell Lung Cancer Therapeutics Product Production Global Market Share
Figure Pfizer Non-small Cell Lung Cancer Therapeutics Product Picture
Table Pfizer Non-small Cell Lung Cancer Therapeutics Product Specification
Table 2010-2015 Pfizer Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Pfizer Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Pfizer Non-small Cell Lung Cancer Therapeutics Product Production Global Market Share
Figure Aetna Non-small Cell Lung Cancer Therapeutics Product Picture
Table Aetna Non-small Cell Lung Cancer Therapeutics Product Specification
Table 2010-2015 Aetna Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Aetna Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Aetna Non-small Cell Lung Cancer Therapeutics Product Production Global Market Share
Figure Boehringer Ingelheim Non-small Cell Lung Cancer Therapeutics Product Picture
Table Boehringer Ingelheim Non-small Cell Lung Cancer Therapeutics Product Specification
Table 2010-2015 Boehringer Ingelheim Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Boehringer Ingelheim Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Boehringer Ingelheim Non-small Cell Lung Cancer Therapeutics Product Production Global Market Share
Figure Celldex Non-small Cell Lung Cancer Therapeutics Product Picture
Table Celldex Non-small Cell Lung Cancer Therapeutics Product Specification
Table 2010-2015 Celldex Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Celldex Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Celldex Non-small Cell Lung Cancer Therapeutics Product Production Global Market Share
Figure Eisai Non-small Cell Lung Cancer Therapeutics Product Picture
Table Eisai Non-small Cell Lung Cancer Therapeutics Product Specification
Table 2010-2015 Eisai Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Eisai Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Eisai Non-small Cell Lung Cancer Therapeutics Product Production Global Market Share
Figure GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Product Picture
Table GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Product Specification
Table 2010-2015 GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Product Production Global Market Share
Figure IMClone Non-small Cell Lung Cancer Therapeutics Product Picture
Table IMClone Non-small Cell Lung Cancer Therapeutics Product Specification
Table 2010-2015 IMClone Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 IMClone Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 IMClone Non-small Cell Lung Cancer Therapeutics Product Production Global Market Share
Figure Merck Serono Non-small Cell Lung Cancer Therapeutics Product Picture
Table Merck Serono Non-small Cell Lung Cancer Therapeutics Product Specification
Table 2010-2015 Merck Serono Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Merck Serono Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Merck Serono Non-small Cell Lung Cancer Therapeutics Product Production Global Market Share
Figure Novartis Non-small Cell Lung Cancer Therapeutics Product Picture
Table Novartis Non-small Cell Lung Cancer Therapeutics Product Specification
Table 2010-2015 Novartis Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Novartis Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Novartis Non-small Cell Lung Cancer Therapeutics Product Production Global Market Share
Figure Qiagen Non-small Cell Lung Cancer Therapeutics Product Picture
Table Qiagen Non-small Cell Lung Cancer Therapeutics Product Specification
Table 2010-2015 Qiagen Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Qiagen Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Qiagen Non-small Cell Lung Cancer Therapeutics Product Production Global Market Share
Figure OncoGenex Non-small Cell Lung Cancer Therapeutics Product Picture
Table OncoGenex Non-small Cell Lung Cancer Therapeutics Product Specification
Table 2010-2015 OncoGenex Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 OncoGenex Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 OncoGenex Non-small Cell Lung Cancer Therapeutics Product Production Global Market Share
Figure OSI Pharmaceuticals Non-small Cell Lung Cancer Therapeutics Product Picture
Table OSI Pharmaceuticals Non-small Cell Lung Cancer Therapeutics Product Specification
Table 2010-2015 OSI Pharmaceuticals Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 OSI Pharmaceuticals Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 OSI Pharmaceuticals Non-small Cell Lung Cancer Therapeutics Product Production Global Market Share
Figure Pierre Fabre Non-small Cell Lung Cancer Therapeutics Product Picture
Table Pierre Fabre Non-small Cell Lung Cancer Therapeutics Product Specification
Table 2010-2015 Pierre Fabre Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Pierre Fabre Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Pierre Fabre Non-small Cell Lung Cancer Therapeutics Product Production Global Market Share
Figure Sanofi Non-small Cell Lung Cancer Therapeutics Product Picture
Table Sanofi Non-small Cell Lung Cancer Therapeutics Product Specification
Table 2010-2015 Sanofi Non-small Cell Lung Cancer Therapeutics Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

Download Unlimited Documents from Trusted Public Sources

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

Opioid Market in the US

  • December 2016
    14 pages
  • Opioid  

  • United States  

View report >

Therapy Market in Denmark - Forecast

  • December 2016
    12 pages
  • Therapy  

  • Denmark  

View report >

Related Market Segments :

Therapy
Lung Cancer

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.